EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

05.12.18

The EPO’s ‘Inventor Award’ Scam: Part II

Posted in Deception, Europe, Patents at 12:08 am by Dr. Roy Schestowitz

Andane Remmal

Summary: The sorts of people whom Battistelli’s EPO grants awards to are sometimes literal frauds and sometimes people who, according to domain experts, did not even deserve the patent they got a prize for

THE EPO is a highly abusive organisation. We’d go further and say corrupt, albeit that typically leads the EPO to trying to SLAPP us. We have never ever seen anything remotely like it at the USPTO, which is reasonably professional. We focus on patent scope there (this has improved in recent years). The USPTO maintains neutrality on patents; no rankings or “awards” (a form of special endorsement)…

EPO insiders can’t stop talking about next month’s event, which will be the passage of EPO budget to Saint-Germain-en-Laye.

As one comment put it a couple of days ago: “Hadn’t you noticed that the EPO is currently under the – I am almost tempted to add “totalitarian” – political control of the deputy mayor of Saint-Germain-en-Laye?”

Does nobody in the mainstream media see the problem with that? It’s not only against the rules (for public servants in international institutions); putting aside the passage of EPO money to Saint-Germain-en-Laye…

“Does nobody in the mainstream media see the problem with that? It’s not only against the rules (for public servants in international institutions); putting aside the passage of EPO money to Saint-Germain-en-Laye…”The remark is in the fifth comment by the way, responding to “MaxDrei” (mentioned/quoted here in relation to its context).

But this post is not about the scandal of Battistelli’s ‘alleged’ misuse of budget or even the award to a literal fraud (whom the EPO now tries to distance itself from — very, very belatedly). This post relates to our first part, which spoke about Morocco, a former French colony which Battistelli seems to be oftentimes leveraging for political agenda. This post is about award for EP1879655B1 (“Advanced [sic] Scientific [sic] Developments” [sic] led by Mr. Remmal).

How much of an invention was it really? Someone who is familiar with this scientific domain looked more closely at it. I should disclose that it’s well outside my field of specialty, so I mostly rely on others for this assessment, which was carried out anonymously.

“How much of an invention was it really?”“It is about the mentioned patent granted to Remmal,” told us a source, “who got the EPO inventor award last year.

“In my opinion there was a lot ado about nothing in the Gazette.”

There was an article about it the Gazette, in French even! [Page 1, Page 2]

“In the present case I am not questioning the probity of Mr. Remmal,” our source said, “but he is definitely NOT the genius that the EPO makes out of him.

“Clinical phytotherapy is a research field since the early 70s. Synergistic effects were investigated with antibiotics alone, and are the basis of aromatherapy. Yet the combination of essential oils and antibiotics and corresponding synergistic effects have been disclosed in 2003 already. See this publication: Bacterial resistance modifying agents from Lycopus europaeus.”

From the Abstract: “As part of an ongoing project to identify plant natural products which modulate bacterial multidrug resistance (MDR), bioassay-guided isolation of an extract of Lycopus europaeus yielded two new isopimarane diterpenes, namely methyl-1alpha-acetoxy-7alpha 14alpha-dihydroxy-8,15-isopimaradien-18-oate (1) and methyl-1alpha,14alpha-diacetoxy-7alpha-hydroxy-8,15-isopimaradien-18-oate (2). The structures were established by spectroscopic methods. These compounds and several known diterpenes were tested for in vitro antibacterial and resistance modifying activity against strains of Staphylococcus aureus possessing the Tet(K), Msr(A), and Nor(A) multidrug resistance efflux mechanisms. At 512 microg/ml none of the compounds displayed any antibacterial activity but individually in combination with tetracycline and erythromycin, a two-fold potentiation of the activities of these antibiotics was observed against two strains of S. aureus that were highly resistant to these agents due to the presence of the multidrug efflux mechanisms Tet(K) (tetracycline resistance) and Msr(A) (macrolide resistance).

Our source continued to stress “that predates the priority date. (2005). Note that this document wasn’t cited – unfortunately – in the search report. This document does not quote carvacrol, carveol or alpha-ionone as constituents of essential oils. But carvacrol and carveol were already known at that time for their antibiotic effect . I see no inventive step there. In my opinion the inventor of the year 2017 was awarded a prize on the basis of an unduly granted patent.”

Research into this has gone on for at least a week. It’s not a rushed judgment. As our source put it, having consulted others as well, “the more I look into the Remmal case, the more I believe we have explosive material. I had the document I referred to double-checked by a specialist and yes I can say that the granted claims do not have the required inventive step.

“But there is more than that. The company owned by Mr.Remmal, Advanced Scientific Developments, is an asset management firm (gestion de valeur mobilere).”

On the day of the priority date (13/5/2005) Mr. Remmal filed 4 applications, namely:

  • US20080171709A1: Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an anti-parasitic agent, and active agent selected among carveol, thymol, eugenol, borneol and carvacrol.
  • US20080214568A1: pharmaceutical combination comprising an antifungal agent and an active substance selected from carveol, eugenol, thymol, borneol, carvacrol, and alpha- and beta-ionones.
  • US20080171768A1: pharmaceutical composition containing an anti-parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone.
  • US20080214518A1: pharmaceutical composition comprising an antibacterial agent and an active ingredient selected from carveol, thymol, eugenol, borneol and carvacrol.

“The last one in its EPO version is the patent on which Remmal received the “inventor” award,” our source remarked. “On all 4 patents the addition of essential oils exhibits a notable synergistic effect, not only with antibiotics but also with antifungal, anti-parasitic, anti-tumoral, antiviral agents. If all this was true, Mr. Remmal would deserve a Nobel prize, not just a dubious EPO inventor award prize.”

“I have also checked the publications by Remmal,” the source noted. “The number and scope of the publications is an indicator of a scientist’s activity. Here is a list. What I see are many publications in the field of essential oils and their medical uses. All these papers are published by Remmal at al but none deals with the use of essential oils in combination with other medications. I find very awkward that none of the publications addresses the subject for which the EP patent was applied for.

“To close the subject, an article published just after Mr. Remmal was awarded the EPO inventor prize [is] a very touching article that looks more like self promotion. I don’t want to judge someone without having an in-depth knowledge of the situation, but considering all the facts I have made my opinion and it is not positive. Frankly, I believe that Remmal is just another troll. What do you think?”

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Only the EPO Goes as Far as Bribing Publishers (the Media) to Promote Software Patents and Publish Fictional Stories

    The world’s patent offices are growing tired of granting software patents which courts later toss out (because these patents are not valid); not only does the EPO advocate such patents — typically using a bundle of buzzwords — it’s also bribing the media to help



  2. EU Needs to Show That It Cares About SMEs and Not 'European Champions' That Are Actually Foreign Monopolies

    Judging by the EU’s nearly blind and unconditional support for the management of the EPO — no matter how abusive and corrupt it has gotten — one has to wonder if the ex-EU official in charge of the EPO reveals a profound democracy deficit as well as growing dangers to Europe’s businesses — the productive firms to which patent maximalism often represents far more risk than opportunity



  3. Guest Article: The Free Software Movement Should Come Out From the Box

    "From now onwards we have to think from a user’s rights perspective and mobilise users of Free software. They should know what rights they ought to get."



  4. IRC Proceedings: Friday, December 13, 2019

    IRC logs for Friday, December 13, 2019



  5. Links 13/12/2019: QEMU 4.2.0, GNU Guile 2.9.7

    Links for the day



  6. Links 13/12/2019: Zorin OS 15.1, Vim 8.2

    Links for the day



  7. Linux Foundation Has Outsourced All the Licence Compliance Stuff to Microsoft, a Serial GPL Violator

    OpenChain Specification/OpenChain Project and Automated Compliance Tooling (ACT) are yet more examples -- the latest of many -- of the Linux Foundation being outsourced to Microsoft, not only for code but also documentation and hosting



  8. IRC Proceedings: Thursday, December 12, 2019

    IRC logs for Thursday, December 12, 2019



  9. Copyleft: Keeping Code Free

    Now that news about "Linux" is dominated by promotion of proprietary software we ought to remember what perpetrators of such a strategy seek to eliminate



  10. Plans That Worked, Plans That Failed

    "I am still looking for good news, but the more good I try to find, the more nastiness I uncover. This is by far, Free software's worst year ever. 2019 Sucks!"



  11. Links 12/12/2019: KDE Applications 19.12, Qt Creator 4.11, New VirtualBox

    Links for the day



  12. Brand Dilution in Action

    Microsoft's proprietary software which spies on people and businesses is getting a "free ride" on the "Linux" brand; and nobody seems to care, nobody seems to notice how perverse that it



  13. At the EPO Money -- Not Quality -- is King

    Financiers are ruining quality



  14. The EPO's Strategic Failure 2023

    Potemkin social dialogue



  15. IRC Proceedings: Wednesday, December 11, 2019

    IRC logs for Wednesday, December 11, 2019



  16. EPO Promoting Software Patents in Countries Where These Are Illegal

    The EPO's vision of 'unitary' software patents (patents on algorithms in countries that disallow such patents, as per their national laws) won't materialise, but in the meantime a lot of Invalid Patents (IPs) are granted in the form of European Patents (EPs) and this is wrong



  17. We Support GNU and the FSF But Remain Sceptical and Occasionally Worry About an RMS-less FSF

    Richard Stallman (RMS) is not in charge of the FSF anymore (it's Stallman who created the FSF) and there's risk the decisions will be made by people who don't share Stallman's ethics or the FSF's spirit



  18. Links 11/12/2019: Huawei Lobbied by Microsoft (Because of GNU/Linux) and Microsoft Still Googlebombs Linux to Promote 'Teams'

    Links for the day



  19. Links 11/12/2019: Edge Native Working Group, CrossOver 19.0 Released

    Links for the day



  20. Instead of Fixing Bug #1 Canonical/Ubuntu Contributes to Making the Bug Even More Severe (WSL/EEE)

    Following one seminal report about Canonical financially contributing to Microsoft's EEE efforts — celebrated openly by GNU/Linux opponentsclosing bug #1 Ubuntu basically decided not that it was fixed but that it would no longer attempt to fix it (“wontfix”)



  21. IRC Proceedings: Tuesday, December 10, 2019

    IRC logs for Tuesday, December 10, 2019



  22. Today's Example of Microsoft's Faked 'Love'

    “On 7 September 2017, users began noticing a message that stated “Skype for Business is now Microsoft Teams”. This was confirmed on 25 September 2017, at Microsoft’s annual Ignite conference,” according to Wikipedia



  23. Links 10/12/2019: Kubernetes 1.17, Debian Init Systems GR

    Links for the day



  24. 'Cancel Culture' as 'Thoughtpolice' Creep

    Richard Stallman spoke about an important aspect of censorship more than 2 decades ago (before “Open Source” even existed); it was published in Datamation (“Censoring My Software”) 23 years before a campaign of defamation on the Internet was used to remove him from MIT and FSF (censoring or ‘canceling’ Stallman himself)



  25. Microsoft Still Hates GNU/Linux and Mark Shuttleworth Knows It (But He is Desperate for Money)

    We're supposed to believe that a PR or image management (reputation laundering) campaign alone can turn Microsoft from GNU/Linux foe into friend/ally



  26. Actions Against EPO Corruption and Unitary Patent (UPC) Injustice/Lobbying

    The EPO is apparently going on strike again and an action against the UPC is scheduled for later this week (protest in Brussels)



  27. “The Fifth Freedom as a Meme”

    The issue with systemd (or SystemD) has provoked or at least stimulated discussions about the limits of the famous Four Freedoms



  28. IRC Proceedings: Monday, December 09, 2019

    IRC logs for Monday, December 09, 2019



  29. Demonstration Against Unitary Software Patents, Thursday 12 Dec in Brussels

    FFII's call to demonstrate against the UPC



  30. Links 9/12/2019: China on GNU/Linux, Canonical Wants Help to Improve Ubuntu

    Links for the day


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts